Historical salary details - Ms. Karin Eastham, Chairman of the Board, Personalis Inc
Ms. Karin Eastham is the Chairman of the Board of Personalis Inc. They also hold 1 other positions in and Veracyte Inc.
Ms. Karin Eastham
Chairman of the Board
$ 165.8 K
Gross Remuneration
-
Current Company
Personalis Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Personalis Inc | Chairman of the Board | 165.8 K | - |
| 2024 | Veracyte Inc | Independent Director | - | - |
| 2023 | Veracyte Inc | Independent Director | 315.0 K | -0.0 % |
| 2023 | Nektar Therapeutics | Independent Director | 62 K | - |
| 2023 | Geron Corp. | Lead Independent Director | - | - |
| 2023 | Personalis Inc | Chairman of the Board | - | - |
| 2022 | Veracyte Inc | Independent Director | 315.0 K | -13.7 % |
| 2022 | Geron Corp. | Lead Independent Director | 214.3 K | 22.6 % |
| 2022 | Personalis Inc | Chairman of the Board | 179.8 K | 7.4 % |
| 2022 | Nektar Therapeutics | Independent Director | - | - |
| 2021 | Nektar Therapeutics | Independent Director | 497.0 K | 1.8 % |
| 2021 | Veracyte Inc | Independent Director | 365.0 K | 89.8 % |
| 2021 | Geron Corp. | Lead Independent Director | 174.8 K | -3.8 % |
| 2021 | Personalis Inc | Independent Director | 167.4 K | 14.5 % |
| 2020 | Nektar Therapeutics | Independent Director | 488.4 K | 38.5 % |
| 2020 | Veracyte Inc | Independent Director | 192.2 K | -6.7 % |
| 2020 | Geron Corp. | Lead Independent Director | 181.7 K | 7.3 % |
| 2020 | Personalis Inc | Independent Director | 146.1 K | -38.3 % |
| 2019 | Nektar Therapeutics | Independent Director | 352.7 K | -69.2 % |
| 2019 | Personalis Inc | Independent Director | 237.0 K | - |
| 2019 | Veracyte Inc | Independent Director | 206.0 K | 88.5 % |
| 2019 | Geron Corp. | Lead Independent Director | 169.4 K | -29.2 % |
| 2019 | Illumina Inc | - | 35.0 K | -92.8 % |
| 2019 | Illumina Inc | Independent Director | - | - |
| 2018 | Nektar Therapeutics | Independent Director | 1.1 M | - |
| 2018 | Illumina Inc | Independent Director | 489.2 K | -0.8 % |
| 2018 | Geron Corp. | Lead Independent Director | 239.4 K | 41.5 % |
| 2018 | Veracyte Inc | Independent Director | 109.3 K | -1.8 % |
| 2017 | Illumina Inc | Independent Director | 493.1 K | 0.6 % |
| 2017 | Geron Corp. | Independent Director | 169.1 K | -2.1 % |
| 2017 | Veracyte Inc | Independent Director | 111.4 K | 34.4 % |
| 2016 | Illumina Inc | Independent Director | 490.1 K | -0.3 % |
| 2016 | Geron Corp. | Independent Director | 172.8 K | 1.5 % |
| 2016 | Veracyte Inc | Independent Director | 82.9 K | -23.7 % |
| 2015 | Illumina Inc | Independent Director | 491.3 K | 1.9 % |
| 2015 | Geron Corp. | Independent Director | 170.3 K | 40.2 % |
| 2015 | Veracyte Inc | Independent Director | 108.6 K | -15.9 % |
| 2014 | Illumina Inc | Independent Director | 482.1 K | -0.0 % |
| 2014 | Veracyte Inc | Independent Director | 129.2 K | -50.9 % |
| 2014 | Geron Corp. | Independent Director | 121.5 K | 24.7 % |
| 2013 | Illumina Inc | Independent Director | 482.2 K | 50.0 % |
| 2013 | Veracyte Inc | Independent Director | 263.1 K | 1334.9 % |
| 2013 | Geron Corp. | Independent Director | 97.4 K | -14.4 % |
| 2012 | Illumina Inc | Independent Director | 321.4 K | -38.6 % |
| 2012 | Geron Corp. | Independent Director | 113.7 K | -36.5 % |
| 2012 | Veracyte Inc | Independent Director | 18.3 K | - |
| 2011 | Illumina Inc | Independent Director | 523.8 K | 14.0 % |
| 2011 | Geron Corp. | Independent Director | 179.0 K | 1.0 % |
| 2010 | Illumina Inc | Independent Director | 459.3 K | 11.6 % |
| 2010 | Geron Corp. | Independent Director | 177.2 K | -22.7 % |
| 2009 | Illumina Inc | Director | 411.5 K | -0.2 % |
| 2009 | Geron Corp. | Director | 229.3 K | - |
| 2008 | Illumina Inc | Director | 412.4 K | 77.1 % |
| 2008 | Geron Corp. | Director | - | - |
| 2007 | Illumina Inc | Director | 232.9 K | 34.6 % |
| 2006 | Illumina Inc | Director | 173.1 K | - |
| 2005 | Illumina Inc | Director | - | - |
| 2004 | Illumina Inc | Director | - | - |